Avaleht › Burkitti lümfoom › Delaware
Burkitti lümfoom kliinilised uuringud osariigis Delaware
7 uuringut haiguse Burkitti lümfoom jaoks otsivad osalejaid osariigis Delaware.
Ametlik uuringutekst (inglise keeles)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Alfred I duPont Hospital for Children, Wilmington
VärbamineFaas 2
366 Days – 46 Years · Kõik sood · Uuendatud 2. okt 2026 · NCT06124157Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT03739814Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Alfred I duPont Hospital for Children, Wilmington
VärbamineFaas 2
365 Days · Kõik sood · Uuendatud 25. sept 2026 · NCT06317662A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Alfred I duPont Hospital for Children, Wilmington
VärbamineFaas 2
Vanused 1–30 · Kõik sood · Uuendatud 1. sept 2026 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Alfred I duPont Hospital for Children, Wilmington
VärbamineFaas 3
365 Days – 25 Years · Kõik sood · Uuendatud 25. aug 2026 · NCT03959085Study of SGR-1505 in Mature B-Cell Neoplasms
- Christiana Care Hospital - Helen F Graham Cancer Center, Newark
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. veebr 2026 · NCT05544019The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington
VärbamineFaas 2
Vanused 1–25 · Kõik sood · Uuendatud 4. mai 2025 · NCT03509961Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.